Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 328 of 328 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/04
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 09/15/97
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 05/31/06
End: -
Due: -
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML | NCT00085709 | SWOG Cancer Research Network | user2@example.com | None | 2004-07-31 | 2014-08-31 | 2015-08-31 | - | - | 2025-07-14 |
| S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma | NCT01563861 | SWOG Cancer Research Network | user2@example.com | None | 1997-09-15 | 2013-10-31 | 2014-10-31 | - | - | 2025-07-14 |
| S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | NCT00335959 | SWOG Cancer Research Network | user2@example.com | None | 2006-05-31 | - | - | - | - | 2025-07-14 |